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Abstract
Intensive glycemic control has become standard practice. Existing
data, however, suggest this practice may have adverse consequen-
ces for traumatic brain injury. The recent paper by Meier and
colleagues suggests that intensive glycemic control may be
deleterious. The present article explores existing literature surroun-
ding this controversy, and outlines the literature that raises
concern. Finally, I suggest an alternative course of action that may
enable control of glucose in an optimal range.
The treatment of traumatic brain injury centers on diligent
intensive care and the prevention of secondary insults. One of
the suspected secondary insults is early hyperglycemia.
There is significant literature that associates early systemic
hyperglycemia with poor neurological outcome after traumatic
brain injury.
The recent paper by Meier and colleagues raises new
concerns about the control of hyperglycemia [1]. Hyper-
glycemia has repeatedly been associated with poor outcome
after traumatic brain injury [2-5], with glucose values
>300 mg/dl (16.6 mmol/l) uniformly associated with fatal
traumatic brain injury in one study [3]. Continued hyper-
glycemia with glucose values >200 mg/dl (11.1 mmol/l) has
been associated with poor outcome [4]. While intensivists
are focused on preventing hyperglycemia, and expend much
clinical effort in achieving normoglycemia, it remains unclear
whether intensive glycemic control during the intensive care
stay is beneficial.
There has been a great deal of enthusiasm for intensive
glycemic control after landmark studies by Van Den Berghe
and colleagues [6,7]. The initial prospective randomized
single-center study of surgical intensive care unit patients
included a small number of brain-injured patients. The overall
results indicated convincingly that intensive glycemic control
was beneficial, and subsequent post-hoc analysis indicated
that intensive glycemic control resulted in less neurologic
complications.
The most recent medical intensive care unit study of intensive
glycemic control was less convincing [8]. In the latter study,
mortality was not reduced in the overall intention-to-treat
group, and a very small positive effect of intensive glycemic
control on mortality was seen in patients treated for >3 days.
At the same time, there remains some concern that intensive
glycemic control (4.4 to 6.1 mmol/l) is not appropriate for
brain-injured patients, and may elicit secondary injury [9].
Using cerebral microdialysis in brain-injured patients, Vespa
and colleagues found that the infusion of insulin to achieve
intensive glycemic control resulted in profound reductions of
brain glucose and in elevation of biomarkers indicating
cellular distress – namely glutamate and lactate/pyruvate
ratio. This finding has been replicated in patients with sub-
arachnoid hemorrhage [10], in which patients with intensive
glycemic control have elevated microdialysis glycerol and
elevated lactate/pyruvate. In addition, there is evidence that
moderate hyperglycemia (12 to 15 mmol/l) is not associated
with adverse events after brain injury [11].
A small single-center randomized trial comparing intensive
glycemic control with moderate hyperglycemia in sub-
arachnoid hemorrhage patients recently failed to demonstrate
a benefit on mortality or vasospasm ischemic insults [12].
There is therefore great uncertainty about how best to control
systemic glycemia after brain injury.
It is in this context that we consider the recent paper of Meier
and colleagues [1]. In this paper, Meier and colleagues
performed a retrospective study comparing the incidence of
hypoglycemia and other adverse consequences when inten-
sive glycemic control (goal of 3.5 to 6.5 mmol/l) was used
versus when loose glycemic control (goal of 5 to 8 mmol/l)
was used. The results are complex and do not indicate that
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intensive glycemic control is beneficial overall. Specifically,
the authors report that the incidence of hypoglycemia and
intracranial hypertension is higher in those patients under-
going intensive glycemic control during the initial week after
injury, and that the rate of bacteremia is higher and urinary
tract infections are worse too. While there was a trend
towards a better intracranial pressure profile during the
second week after injury in the intensive control group, the
preponderance of data points against the use of intensive
glycemic control. This finding stands in sharp contrast to the
results of Van Den Berghe and colleagues [8], in which the
incidence of intracranial hypertension and of mean intra-
cranial pressure was less in the group undergoing intensive
glycemic control. Moreover, Meier and colleagues report a
trend towards worsened survival at 21 days after brain injury
in the intensive glycemic control group. This unexpected
worsening of mortality is cause for great concern among
those who advocate intensive glycemic control in brain trauma.
The stage is clearly set for prospective study of glycemic
control. In our center we have begun to use cerebral
microdialysis and positron emission tomography to prospec-
tively identify the ideal lowest glycemic range that appears to
be safe from the brain’s metabolic perspective. The
operational definition of a lowest safe glycemic range may not
be uniform among patients, and is as yet unclear. The lowest
safe glycemic range will probably be defined by the serum
glucose value that does not elicit metabolic disturbance in
the brain, as measured by sophisticated brain monitors such
as microdialysis and positron emission tomography.
Once the lowest safe glycemic range is identified, a
multicenter randomized control trial will be needed to deter-
mine whether some form of glycemic control is better than
moderate hyperglycemia for brain-injured patients. For now –
given the cumulative evidence that intensive glycemic control
is associated with metabolic distress [9], with increased
hypoglycemia, with worsened intracranial pressure, and with
worsened mortality [1] – the ideal range for glycemic control
is unclear.
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